Navigation Links
Nora Therapeutics to Present at the Oppenheimer 24th Annual Healthcare Conference
Date:12/2/2013

PALO ALTO, Calif., Dec. 2, 2013 /PRNewswire/ -- Nora Therapeutics announced today that CEO Jeffrey K. Tong, Ph.D., will present at the Oppenheimer 24th Annual Healthcare Conference. The conference will take place Dec. 10 - 11 at the Crowne Plaza Hotel in New York City.

Dr. Tong will be presenting on Tuesday, Dec. 10 at 11:30 a.m. (EST). Investors attending the conference who would like to meet with Nora should contact their Oppenheimer representative or the Company. For additional information on Nora, please visit the Company's website at www.noratherapeutics.com.

About Nora Therapeutics, Inc.

Nora Therapeutics, Inc., is a specialty biopharmaceutical company focused on developing therapeutics to address unmet clinical needs in reproductive medicine. Nora's lead compound, NT100, is being specifically designed and developed for use following in vitro fertilization (IVF) procedures to improve pregnancy success rates and outcomes. NT100 is a novel biologic agent similar to a naturally occurring protein in the female reproductive tract. NT100's mechanism of action may better enable embryo implantation and pregnancy maintenance by optimizing maternal-fetal immune tolerance. For more information about Nora Therapeutics, visit www.noratherapeutics.com.

 

 


'/>"/>
SOURCE Nora Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015 With ... cytometry is experiencing a rise in active partnerships. ... in underdeveloped nations to quantitate CD4 cell markers ... Logo - http://photos.prnewswire.com/prnh/20150831/262206LOGO ... the Global Flow Cytometry Market ( http://www.frost.com/nf0e ), ...
(Date:8/31/2015)...  The departments of Drug and Alcohol Programs (DDAP) ... 90 to raise awareness for International Overdose Awareness Day ... Pennsylvania and help more Pennsylvanians with substance ... the Building Bridges to Recovery initiative. ... to a disease that is fully treatable, if given ...
(Date:8/31/2015)... Pharmacy, Inc. (NYSE: DPLO ), the nation,s largest independent ... & CEO, and Sean Whelan , CFO, will present ... and Mr. Whelan are scheduled to participate in the Wells ... on Wednesday, September 9, 2015 at 1:45 PM ET. ... participate in the Robert W. Baird 2015 Healthcare Conference in ...
Breaking Medicine Technology:Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2Diplomat to Participate in Upcoming Investor Conferences 2
... LOS ANGELES--(BUSINESS WIRE)--May 21, 2007 - Cougar Biotechnology,Inc. ... Phase,II data on the Company's prostate cancer drug ... Urological,Association (AUA) Annual Meeting, which is currently taking ... Dr. Timothy A.,Yap from the Cancer Research UK ...
... WIRE)--May 21, 2007 - Medical,professionals seeking to ... gram-negative pneumonia may have a new weapon:,NKTR-061 ... by Nektar Therapeutics (Nasdaq:NKTR)., Results of a ... of,NKTR-061 (Inhaled Amikacin) to treat mechanically ventilated,patients ...
Cached Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11
(Date:9/1/2015)... , ... September 01, 2015 , ... ... Kit is now available. With the Connectivity Kit, EasySampler data is ... jacketed lab reactor control experiment, on a touchscreen platform. , EasySampler fully ...
(Date:9/1/2015)... ... September 01, 2015 , ... The PracticeMatch ... 8:00 pm at the Marriott Indianapolis Downtown, 350 West Maryland Street, Indianapolis, IN ... attending from across the country. All specialties will be represented. Attendees will enjoy ...
(Date:9/1/2015)... OHIO (PRWEB) , ... September 01, 2015 , ... Dr. ... today at JourneyLite of Cincinnati. In the last month the FDA has approved ... ReShape Duo ™. These procedures represent the first incisionless, reversible, weight loss procedures ...
(Date:9/1/2015)... ... 2015 , ... Elizabeth Callahan, MD, founder and medical director of SkinSmart ... offer RADIESSE® filler treatment for volume loss in the hands. RADIESSE provides an immediate ... the hands, delivering smooth, natural-looking results that can last up to one year in ...
(Date:9/1/2015)... ... September 01, 2015 , ... September is Baby Safety Month, and Lightning ... stickers to keep little ones' safety top of mind at all times. , Sponsored ... focus. According to the JPMA's Baby Safety Zone website, this year's theme is A ...
Breaking Medicine News(10 mins):Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 2Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 3
... this as troubling individually and for society , WEDNESDAY, ... mobility are increasing among middle-age Americans, a new study ... long-term consequences for the U.S. health-care system. , Researchers ... data from the annual National Health Interview Survey, covering ...
... ... Services. , ... Mississauga, Ontario (PRWEB) April 7, 2010 -- CentriLogic , a leading ... first international, multi-infrastructure cloud computing service based in Canada. The new ...
... ... Inc., a leader in advanced 3D-5D visualization and analysis software solutions for the ... a leading distributor of medical technology in Greece. Intrahealth, located in Athens, will ... country. , ...
... Tahitian ... Noni Bioactive Beverages , ... UT (Vocus) April 7, 2010 -- Tahitian Noni International (TNI) announced that five ... has responded. Tahitian Noni International believes that no other product in the industry will measure ...
... , ... global technology leader in the live archiving space, MessageSolution is the first SaaS and ... server platforms, including Exchange, Domino, GroupWise, file systems and SharePoint, delivering compliance archiving for ... ...
... ... sealed, waterproof and is designed and tested for reliable operation in the most extreme ... viewing in all lighting conditions, including daylight. The SDC100HB is specifically designed for the ... industries. , ...
Cached Medicine News:Health News:Middle-Age Americans Less Mobile Than Ever 2Health News:CentriLogic Launches First Canadian-Based Distributed Cloud Computing Service 2Health News:CentriLogic Launches First Canadian-Based Distributed Cloud Computing Service 3Health News:Ziosoft Expands PhyzAiodynamic Diagnostic Solutions into Greek Healthcare Market 2Health News:Ziosoft Expands PhyzAiodynamic Diagnostic Solutions into Greek Healthcare Market 3Health News:Not All Fruits Are Superfruits: Not One Network Marketing Superfruit Company Has Accepted Tahitian Noni's Challenge 2Health News:MessageSolution Exhibits Cloud-Based Integrated Archiving Solution for Email, File Systems and SharePoint at SaaSCon 2010, Kicks off MessageSolution SaaS Tour 2010 2Health News:MessageSolution Exhibits Cloud-Based Integrated Archiving Solution for Email, File Systems and SharePoint at SaaSCon 2010, Kicks off MessageSolution SaaS Tour 2010 3Health News:MessageSolution Exhibits Cloud-Based Integrated Archiving Solution for Email, File Systems and SharePoint at SaaSCon 2010, Kicks off MessageSolution SaaS Tour 2010 4Health News:MessageSolution Exhibits Cloud-Based Integrated Archiving Solution for Email, File Systems and SharePoint at SaaSCon 2010, Kicks off MessageSolution SaaS Tour 2010 5Health News:MessageSolution Exhibits Cloud-Based Integrated Archiving Solution for Email, File Systems and SharePoint at SaaSCon 2010, Kicks off MessageSolution SaaS Tour 2010 6Health News:Rugged High Bright Touch Screen Computer Designed and Tested for the Most Extreme Environments 2Health News:Rugged High Bright Touch Screen Computer Designed and Tested for the Most Extreme Environments 3
The CALBIOTECH, INC. (CBI), Mumps IgM ELISA tests system is an enzyme linked immunosorbent assay (ELISA) for the detection of IgM class antibodies to Mumps in human serum or plasma....
... is comprised of the TEG analyzer and the ... picture of the formation and dissolution of the ... two systems. ,Haemoscope's TEG analyzer is the only ... the reliable and proven model developed by Prof. ...
With BareWire technology, the wire crosses the lesion first, independent of the filter and delivery catheter. All other actions, including filter placement and retrieval, balloon dilatations, and ste...
... is supported on NT / 2000 platforms. ... to effectively work in a multi-user, networked ... move comfortably to an enhanced level of ... improving the quality of patient care. , ...
Medicine Products: